CAMX:STO
Camurus AB
SEK 739.50
arrow_downward
-0.07%(-0.50) 1D
Nob 20, 5:29:43 PM GMT+1 · SEK
search
Lahat ng simbolo
| Simbolo | Presyo | Palitan | % ng Pagbabago |
|---|
insights_autoBumubuo ng mga nangungunang insight para sa CAMX...
Buksan
SEK 738.50
Mataas
SEK 745.50
Mababa
SEK 733.50
Mkt. cap
44.78B
Avg. na dami
103.71K
Dami
71.53K
Mataas nang 52-wk
SEK 750.00
Mababa nang 52-wk
SEK 430.80
Mga natitirang share
60.56M
Bilang ng mga empleyado
323
Buksan
SEK 738.50
Mataas
SEK 745.50
Mababa
SEK 733.50
Mkt. cap
44.78B
Avg. na dami
103.71K
Dami
71.53K
Mataas nang 52-wk
SEK 750.00
Mababa nang 52-wk
SEK 430.80
Mga natitirang share
60.56M
Bilang ng mga empleyado
323
Mga balita at kwento
Mula sa mga source sa web at partner sa balita
24/7 Wall St.
·
10 minuto ang nakalipas
Billionaire Ray Dalio's Bridgewater Keeps 16% of Its $23 Billion Stock Portfolio in S&P 500 Index Funds, Even After Cutting Them
Crypto Briefing
·
1 oras ang nakalipas
Nasdaq slides deeper as Nvidia rout drags S&P 500 and Dow into correction
Yahoo Finance
·
1 oras ang nakalipas
The S&P 500 Just Whipsawed Near a Record High. Here’s Why I’m Lowering My Expectations, Not Selling.
TradingView
·
3 oras ang nakalipas
Yardeni Trims S&P 500 Year-End Forecast Again, Says Bear Market Is Unlikely
Profile
Camurus AB is a Swedish research-based pharmaceutical and biotechnology company specialising in the commercialization of medicines for treating serious and chronic diseases. Established in 1991 and based in the southern university city of Lund, in the Medicon Valley region, the company is listed on Nasdaq Stockholm, Mid Cap.
Camurus was founded by scientists in biophysical, food, and pharmaceutical chemistry with expertise in lipid phase structures. The company provides nanoscale drug-delivery systems for development of high-value therapeutics. Wikipedia
Tungkol sa Camurus AB
CEOFredrik Tiberg
Mga Empleyado323
Itinatag1991
Headquarters-
SektorHealth Care
Industriya-
Websitecamurus.com